348 related articles for article (PubMed ID: 28774842)
1. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
[TBL] [Abstract][Full Text] [Related]
2. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
[TBL] [Abstract][Full Text] [Related]
3. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
4. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
5. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
[TBL] [Abstract][Full Text] [Related]
6. Transport Mechanisms of Butyrate Modified Nanoparticles: Insight into "Easy Entry, Hard Transcytosis" of Active Targeting System in Oral Administration.
Wu L; Bai Y; Liu M; Li L; Shan W; Zhang Z; Huang Y
Mol Pharm; 2018 Sep; 15(9):4273-4283. PubMed ID: 30102863
[TBL] [Abstract][Full Text] [Related]
7. A novel ligand conjugated nanoparticles for oral insulin delivery.
Liu C; Shan W; Liu M; Zhu X; Xu J; Xu Y; Huang Y
Drug Deliv; 2016 Jul; 23(6):2015-25. PubMed ID: 26203690
[TBL] [Abstract][Full Text] [Related]
8. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules via Improving Payload Stability and Regulating the Transcytosis Pathway.
Zheng Y; Wu J; Shan W; Wu L; Zhou R; Liu M; Cui Y; Zhou M; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Oct; 10(40):34039-34049. PubMed ID: 30207680
[TBL] [Abstract][Full Text] [Related]
10. The use of low molecular weight protamine to enhance oral absorption of exenatide.
Zhang L; Shi Y; Song Y; Sun X; Zhang X; Sun K; Li Y
Int J Pharm; 2018 Aug; 547(1-2):265-273. PubMed ID: 29800739
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems.
Bai Y; Zhou R; Wu L; Zheng Y; Liu X; Wu R; Li X; Huang Y
J Mater Chem B; 2020 Apr; 8(13):2636-2649. PubMed ID: 32129375
[TBL] [Abstract][Full Text] [Related]
12. Hydrophilic and Electroneutral Nanoparticles to Overcome Mucus Trapping and Enhance Oral Delivery of Insulin.
Tan X; Yin N; Liu Z; Sun R; Gou J; Yin T; Zhang Y; He H; Tang X
Mol Pharm; 2020 Sep; 17(9):3177-3191. PubMed ID: 32697099
[TBL] [Abstract][Full Text] [Related]
13. Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
Czuba E; Diop M; Mura C; Schaschkow A; Langlois A; Bietiger W; Neidl R; Virciglio A; Auberval N; Julien-David D; Maillard E; Frere Y; Marchioni E; Pinget M; Sigrist S
Int J Pharm; 2018 May; 542(1-2):47-55. PubMed ID: 29501738
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic Viruslike and Charge Reversible Nanoparticles to Sequentially Overcome Mucus and Epithelial Barriers for Oral Insulin Delivery.
Wu J; Zheng Y; Liu M; Shan W; Zhang Z; Huang Y
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9916-9928. PubMed ID: 29504398
[TBL] [Abstract][Full Text] [Related]
15. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of hydroxyapatite nanoparticles carrying insulin and gallic acid for insulin oral delivery.
Zhang Y; Zhang L; Ban Q; Li J; Li CH; Guan YQ
Nanomedicine; 2018 Feb; 14(2):353-364. PubMed ID: 29157980
[TBL] [Abstract][Full Text] [Related]
17. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
18. Thiolated Eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation.
Zhang Y; Wu X; Meng L; Zhang Y; Ai R; Qi N; He H; Xu H; Tang X
Int J Pharm; 2012 Oct; 436(1-2):341-50. PubMed ID: 22766443
[TBL] [Abstract][Full Text] [Related]
19. In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles.
Reix N; Parat A; Seyfritz E; Van der Werf R; Epure V; Ebel N; Danicher L; Marchioni E; Jeandidier N; Pinget M; Frère Y; Sigrist S
Int J Pharm; 2012 Nov; 437(1-2):213-20. PubMed ID: 22940208
[TBL] [Abstract][Full Text] [Related]
20. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration.
Urimi D; Agrawal AK; Kushwah V; Jain S
AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
